HighVista Strategies »

4d Molecular Therapeutics In shares owned by HighVista Strategies

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2023-09-30 $425k 33k 12.73

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Activision Blizzard
Vmware Cl A Com
Albertsons Cos Common Stock (ACI)
Immunovant (IMVT)
Capri Holdings SHS (CPRI)
Horizon Therapeutics Pub L SHS
stock
Seagen
Axsome Therapeutics (AXSM)
Structure Therapeutics Sponsored Ads (GPCR)
Amedisys (AMED)
Ideaya Biosciences (IDYA)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Microsoft Corporation (MSFT)

View all positions for HighVista Strategies

Top funds holding 4d Molecular Therapeutics In

Viking Global Investors
RA Capital Management
BVF
VR Adviser
Henderson Group
Vanguard Group
Arrowpoint Asset Management
Casdin Capital
Goldman Sachs Group
Dimensional Fund Advisors
Deutsche Bank Aktiengesellschaft
Eagle Health Investments
Assenagon Asset Management
Jpmorgan Chase & Co
Point72 Asset Management

View all funds holding 4d Molecular Therapeutics In